The Government of Indonesia launched a national measles-rubella immunisation campaign targeting all Indonesian children between the ages of nine months and 15 years. The campaign will aim to reach 95% immunisation coverage and thus eliminate measles and rubella in Indonesia by 2020.
Thirty five million children are expected to receive the measles-rubella vaccine during the campaign’s first phase which will be held in the Java region from August to September 2017. It will be conducted in 3,569 public health centres in 119 districts spread across six provinces. The second phase will cover all other regions outside of Java and will be conducted in August-September 2018.
“I congratulate the Government of Indonesia on this landmark campaign”, said Gavi Deputy CEO Anuradha Gupta. “Measles is one of the most contagious diseases known to humanity and claims one life every four minutes - mostly children. Similarly, for millions of mothers and their children across the world, rubella poses a serious and ongoing threat and, if contracted during early pregnancy, can cause defects of the brain, heart, eyes, and ears. Yet for less than a dollar per dose these diseases can be easily prevented with a safe and effective vaccine. This campaign and the subsequent introduction of a combined measles-rubella vaccine in Indonesia’s national immunisation programme will be a game changer in the fight against these infections”, she added.